WO2025169223 - AMORPHOUS SOLID DISPERSIONS OF ASUNDEXIAN
National phase entry is expected:
Publication Number
WO/2025/169223
Publication Date
14.08.2025
International Application No.
PCT/IN2025/050134
International Filing Date
04.02.2025
Title **
[English]
AMORPHOUS SOLID DISPERSIONS OF ASUNDEXIAN
[French]
DISPERSIONS SOLIDES AMORPHES D'ASUNDEXIAN
Applicants **
DR. REDDY'S LABORATORIES LIMITED
Inventors
JHA, Romesh
BHATTACHARYA, Saswati
ARORA, Sachin
KADAM, Sainath Digambar
BORADE, Jayashree Raju
NEKKANTI, Satish Chowdary
PAL DATTA, Sharmistha
BHARGAVA, Ankur
HANDA, Ajay Kumar
KULKARNI, Sushrut
Priority Data
202441007648
05.02.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2189 | |
| EPO | Filing, Examination, Granting | 13118 | |
| Japan | Filing, Examination, Granting | 2254 | |
| South Korea | Filing, Examination, Granting | 2318 | |
| USA | Filing, Examination, Granting | 10740 |
Total:
30,619
Contact Us
Abstract[English]
: The present invention relates to amorphous solid dispersions of Asundexian, and pharmaceutical compositions thereof. The present invention particularly relates to solid pharmaceutical dosage forms comprising amorphous solid dispersions of Asundexian and one or more pharmaceutically acceptable carrier selected from the group consisting of Gelucire, TPGS, PVAP Microcrystalline cellulose, Lactose monohydrate, Cross Carmellose sodium, Prosolv, Talc and mixture thereof.[French]
: La présente invention concerne des dispersions solides amorphes d'asundexian, et des compositions pharmaceutiques de celles-ci. La présente invention concerne en particulier des formes posologiques pharmaceutiques solides comprenant des dispersions solides amorphes d'asundexian et un ou plusieurs supports pharmaceutiquement acceptables choisis dans le groupe constitué par le gélucire, TPGS, la cellulose microcristalline PVAP, le monohydrate de lactose, le croscarmellose sodique, le prosolv, le talc et leur mélange.